Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Nucynta

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
AbstractTapentadol (Nucynta) is a centrally acting opioid analgesic prescribed for the treatment of moderate to severe acute pain… Expand
Is this relevant?
2012
2012
Tapentadol is a DEA schedule II opioid medication with a safety profile, duration of action, frequency of dosing, and analgesic… Expand
Is this relevant?
2011
2011
New formulation: Tapentadol extended release tablets were FDA approved for the management of moderate-to-severe chronic… Expand
Is this relevant?
2009
2009
  • The Medical letter on drugs and therapeutics
  • 2009
  • Corpus ID: 44910354
The FDA has approved tapentadol hydrochloride (Nucynta--Ortho-McNeil Janssen) for oral treatment of moderate to severe acute pain… Expand
Is this relevant?